More on 4D4A
News
- DIAGNOS to Present at the Emerging Growth Conference on June 10, 2026
- DIAGNOS Announces Amendment to Convertible Debentures
- DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA
- DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration
- DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants
- DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference
- DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation
- DIAGNOS Announces the Engagement of IBN
- DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress
- DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence (AI) Scientist to Accelerate our Innovation in Healthcare
Entities mentioned with 4D4A
- FDA | View Related Stories »
- JPMorgan | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- Charles Gasparino | View Related Stories »
- Ron Insana | View Related Stories »
- John McCain | View Related Stories »
- Show More...
